Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 7/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | XDH | P47989 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10173065 | 0.85 | CYP3A4 (0.60) | TDP1ALDH1A1CYP3A4TSHRGAA | |
| SCHEMBL3030993 | 0.82 | LMNA (0.56) | TDP1ALDH1A1CYP3A4TSHRGAA | |
| SCHEMBL78293 | 0.79 | CYP3A4 (0.69) | TDP1ALDH1A1CYP3A4TSHRGAA | |
| SCHEMBL29353815 | 0.79 | CYP3A4 (0.69) | TDP1ALDH1A1CYP3A4TSHRGAA | |
| SCHEMBL392484 | 0.78 | TDP1 (0.61) | TDP1ALDH1A1CYP3A4TSHRGAA | |
| SCHEMBL2569715 | 0.78 | GPR35 (0.59) | TDP1ALDH1A1CYP3A4TSHRGAA | |
| SCHEMBL222956 | 0.77 | XDH (0.67) | TDP1ALDH1A1CYP3A4TSHRHTT | |
| Hydrochloric Acid SCHEMBL970605 | 0.77 | CYP3A4 (0.67) | TDP1ALDH1A1CYP3A4TSHRGAA | |
| Methane SCHEMBL28785435 | 0.77 | CYP3A4 (0.67) | TDP1ALDH1A1CYP3A4TSHRGAA | |
| SCHEMBL11684415 | 0.77 | TDP1 (0.65) | TDP1ALDH1A1CYP3A4TSHRGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 340 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119039285-A | Bisindole crown ether diamine and preparation method and application thereof | 西南科技大学 | 2024-11-29 | — | — | CN | claimed |
| CN-118852686-A | Epoxy resin film and preparation method thereof | 西南科技大学 | 2024-10-29 | — | — | CN | claimed |
| CN-111892553-A | Method for synthesizing ammonium acetate mediated benzothiazole compound | 衡阳师范学院 | 2020-11-06 | — | — | CN | claimed |
| US-20070191488-A1 | Method for the treatment of a ubiquitin conjugating disorder | BANERJEE AMIT | 2007-08-16 | — | — | US | claimed |
| EP-1778011-A2 | COMPOUNDS AND METHODS FOR THE TREATMENT OF UBIQUITIN CONJUGATING DISORDERS | Hygeia Biological Systems (US) | 2007-05-02 | — | — | EP | claimed |
| WO-2006020681-A2 | COMPOUNDS AND METHODS FOR THE TREATMENT OF UBIQUITIN CONJUGATING DISORDERS | HYGEIA BIOLOGICAL SYSTEMS (US) | 2006-02-23 | — | — | WO | claimed |
| US-20060035890-A1 | Compounds and methods for the treatment of ubiquitin conjugating disorders | AMIT BANERJEE | 2006-02-16 | — | — | US | claimed |
| US-12577267-B2 | Pyrimidine compounds for use as MAP4K1 inhibitors | GLENMARK SPECIALITY S.A. (CH) | 2026-03-17 | — | — | US | disclosed |
| US-20250312362-A1 | INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | MERCK SHARP & DOHME LLC (US) | 2025-10-09 | — | — | US | disclosed |
| US-RE50453-E1 | Indole derivatives as CFTR modulators | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-06-10 | — | — | US | disclosed |
| EP-4525851-A1 | INHIBITORS OF MSBA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | Merck Sharp & Dohme LLC (US) | 2025-03-26 | — | — | EP | disclosed |
| WO-2025034034-A1 | NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER OR TUMORS COMPRISING SAME | 주식회사 대웅제약 | 2025-02-13 | — | — | WO | disclosed |
| CN-119039285-A | Bisindole crown ether diamine and preparation method and application thereof | 西南科技大学 | 2024-11-29 | — | — | CN | disclosed |
| EP-0644187-A1 | Antimigraine cyclobutenedione derivatives of tryptamines | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-03-22 | — | — | EP | disclosed |
| US-5382592-A | Antimigraine cyclobutenedione derivatives of tryptamines | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-01-17 | — | — | US | disclosed |
| US-4567280-A | NITROGEN DIOXIDE; BY-PRODUCT INHIBITION | UBE INDUSTRIES, LTD. (JP) | 1986-01-28 | — | — | US | disclosed |
| US-4239708-A | P-Phenylene bis[imino(thiocarbonyl)] diphosphoramidic acid esters as anthelmentic agents | AMERICAN CYANAMID COMPANY (US) | 1980-12-16 | — | — | US | disclosed |
| US-4172098-A | REACTION OF A HALOAMINOBENZOIC ACID WITH AN ALCOHOL AND NITROSYLATING AGENT IN THE PRESCENCE OF AN ACID AND WATER | BASF AKTIENGESELLSCHAFT (DE) | 1979-10-23 | — | — | US | disclosed |
| US-4137310-A | LARVICIDES | AMERICAN CYANAMID COMPANY (US) | 1979-01-30 | — | — | US | disclosed |
| US-4053527-A | REACTING HALONITROANILINES WITH ALCOHOLS AND NITROSATING AGENTS ION | BASF AKTIENGESELLSCHAFT (DT) | 1977-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577267-B2 | Pyrimidine compounds for use as MAP4K1 inhibitors | PTK2B, MAP3K10, MAP3K20 | TDP1 714/4885ALDH1A1 4346/4885CYP3A4 3045/4885 |
| US-20250312362-A1 | INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | MSRB3, ABCC1, MRPS34 | TDP1 4765/4885ALDH1A1 4233/4885CYP3A4 900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.